These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1937934)

  • 1. Biologically active heparin coating in medical devices.
    Olsson P; Larm O
    Int J Artif Organs; 1991 Aug; 14(8):453-6. PubMed ID: 1937934
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
    Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bound and circulating heparin in an ECMO system thrombogenicity versus functionality.
    Roohk HV; Calabrese D; Sanematsu L; Castillo G; Cottonaro CN
    Trans Am Soc Artif Intern Organs; 1984; 30():639-43. PubMed ID: 6533950
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of heparin coating on the expression of CD11b, CD11c and CD62L by leucocytes in extracorporeal circulation in vitro.
    Høgevold HE; Moen O; Fosse E; Venge P; Bråten J; Andersson C; Lyberg T
    Perfusion; 1997 Mar; 12(1):9-20. PubMed ID: 9131716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of open heart surgery tubing coated with heparin and lipid.
    Novello WP; Santana MH; Fonseca De Arruda AC
    Artif Organs; 2000 Mar; 24(3):182-4. PubMed ID: 10759636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Product design and its relation to the generation of gaseous microemboli in the extracorporeal circuit.
    Servas FM
    Med Instrum; 1985; 19(2):63-6. PubMed ID: 4000008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo testing of heparin-coated extracorporeal circuits: bovine experiments.
    Weerwind PW; van der Veen FH; Lindhout T; de Jong DS; Cahalan PT
    Int J Artif Organs; 1998 May; 21(5):291-8. PubMed ID: 9684912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The benefit of heparin-bound circuits.
    Moulijn AC; Amsel BJ
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):557-8. PubMed ID: 8751535
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin-coated versus non-coated surfaces for extracorporeal circulation.
    Mottaghy K; Oedekoven B; Pöppel K; Kovacs B; Kirschfink M; Bruchmüller K; Kashefi A; Geisen C
    Int J Artif Organs; 1991 Nov; 14(11):721-8. PubMed ID: 1757160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New surface treatments to prevent thrombosis during extracorporeal circulation.
    Splittgerber FH; Whittlesey GC; Klein MD
    Trans Am Soc Artif Intern Organs; 1985; 31():474-8. PubMed ID: 3837492
    [No Abstract]   [Full Text] [Related]  

  • 11. Phosphorylcholine or heparin coating for pediatric extracorporeal circulation causes similar biologic effects in neonates and infants.
    Böning A; Scheewe J; Ivers T; Friedrich C; Stieh J; Freitag S; Cremer JT
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1458-65. PubMed ID: 15116008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation.
    Meinhardt JP; Annich GM; Miskulin J; Kawai T; Ashton BA; Bartlett RH
    ASAIO J; 2003; 49(4):395-400. PubMed ID: 12918580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygenator thrombosis: worst case after development of an abnormal pressure gradient--incidence and pathway.
    Wendel HP; Philipp A; Weber N; Birnbaum DE; Ziemer G
    Perfusion; 2001 Jul; 16(4):271-8. PubMed ID: 11486845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin cofactor activity during and after extracorporeal circulation with bubble and membrane oxygenators.
    Weiss M; Blass J; Leau A; Verriest C
    Biomedicine; 1977 Oct; 27(7):248-9. PubMed ID: 73390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of bound heparin in prolonged extracorporeal membrane oxygenation.
    Toomasian JM; Zwischenberger JB; Oram AD; DeSmet GM; Bartlett RH
    Trans Am Soc Artif Intern Organs; 1984; 30():133-6. PubMed ID: 6533877
    [No Abstract]   [Full Text] [Related]  

  • 16. [The gas-exchange properties of membrane blood oxygenators with immobilized heparin].
    Cherkas DD; Skorik VI; Novikova SP; Shilov VV; Kazakov SP
    Anesteziol Reanimatol; 1992; (4):56-7. PubMed ID: 1485678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term extracorporeal blood bypass in dogs at low flows without systemic heparinization. Heparin-coated versus uncoated circuits.
    van der Hulst VP; Gründeman PF; Moulijn AC; Rutten PJ; Klopper PJ
    ASAIO Trans; 1991; 37(4):577-83. PubMed ID: 1768492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of flexible, kink-resistant, silicone rubber catheters.
    Alexandrou B; Read R; Li SK
    J Med Eng Technol; 1978 Mar; 2(2):75-6. PubMed ID: 264214
    [No Abstract]   [Full Text] [Related]  

  • 19. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
    Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation and antithrombogenicity of oxidated low molecular weight heparin-antithrombin complex coated-polyvinyl chloride tubing].
    Luo P; Liu W; Yang C; Zhou H; Cao R; Yang J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Feb; 28(1):90-4. PubMed ID: 21485191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.